NEW
Vascepa

Vascepa

icosapent ethyl

Manufacturer:

Amarin

Distributor:

Hind Wing
Concise Prescribing Info
Contents
Icosapent ethyl
Indications/Uses
Reduces risk of CV events (CV death, non-fatal MI, non-fatal stroke, coronary revascularization or hospitalization for unstable angina) in statin-treated patients w/ elevated triglycerides, who are at high risk of CV events due to: established CV disease; or diabetes & at least 1 other CV risk factor.
Dosage/Direction for Use
Administration
Should be taken with food.
Contraindications
Special Precautions
Do not substitute w/ or combine w/ other products containing omega-3 fatty acids. Associated w/ increased incidence of bleeding. Caution in patients w/ known hypersensitivity to fish &/or shellfish. Periodically monitor ALT & AST levels during therapy in patients w/ hepatic impairment. Not recommended during pregnancy & in nursing women. Not indicated for ped use.
Adverse Reactions
Peripheral edema, constipation, atrial fibrillation.
Drug Interactions
Increased risk of bleeding w/ concomitant antithrombotic medications eg, aspirin, clopidogrel, or warfarin.
MIMS Class
Dyslipidaemic Agents
ATC Classification
C10AX06 - omega-3-triglycerides incl. other esters and acids ; Belongs to the class of other lipid modifying agents.
Presentation/Packing
Form
Vascepa soft gel cap 1 g
Packing/Price
120's
Exclusive offer for doctors
Register for a MIMS account and receive free medical publications worth $768 a year.
Already a member? Sign in
Exclusive offer for doctors
Register for a MIMS account and receive free medical publications worth $768 a year.
Already a member? Sign in